Not Signed In -
Alcohol-related birth defects |
|
|
Clinical Trial: Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
This study has been completed.
Purpose
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Alcohol-Related Disorders Cocaine-Related Disorders | Drug: Naltrexone | Phase II |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients
Eligibility
Ages Eligible for Study: 18 Years - 50 Years, Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
Texas
University of Texas Health Science Center, Houston, Texas, 77225, United States
Study chairs or principal investigators
John Grabowski, Ph.D., Principal Investigator, University of Texas
More Information
Study ID Numbers: NIDA-09262-4; P50-09262-4
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000307
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000307
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- What Is Fetal Alcohol Syndrome? (MayoClinic)
email this page
print this page
bookmark this page
feedback on this page
